Aprogen Medicines Inc. (KRX:007460)

South Korea flag South Korea · Delayed Price · Currency is KRW
304.00
+3.00 (1.00%)
Apr 3, 2026, 3:30 PM KST
Market Cap93.80B -56.9%
Revenue (ttm)117.97B -21.4%
Net Income-70.20B
EPS-236.00
Shares Out308.55M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,492,744
Average Volume8,011,378
Open317.00
Previous Close301.00
Day's Range300.00 - 317.00
52-Week Range292.00 - 938.00
Beta0.16
RSI37.67
Earnings DateMay 13, 2026

About Aprogen Medicines

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foam... [Read more]

Industry Conglomerates
Founded 2000
Employees 256
Stock Exchange Korea Stock Exchange
Ticker Symbol 007460
Full Company Profile

Financial Performance

In 2025, Aprogen Medicines's revenue was 117.97 billion, a decrease of -21.41% compared to the previous year's 150.11 billion. Losses were -70.20 billion, 20.9% more than in 2024.

Financial Statements